Walgreens Boots Alliance (NASDAQ:WBA) Releases Earnings Results, Beats Estimates By $0.13 EPS

Walgreens Boots Alliance (NASDAQ:WBA) issued its quarterly earnings results on Friday. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13, RTT News reports. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The firm had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same period last year, the company earned $0.66 EPS. Walgreens Boots Alliance’s quarterly revenue was up 7.6% compared to the same quarter last year. Walgreens Boots Alliance updated its FY 2025 guidance to 1.400-1.800 EPS and its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $9.22 on Friday. The company has a 50 day moving average of $9.21 and a two-hundred day moving average of $9.92. Walgreens Boots Alliance has a twelve month low of $8.08 and a twelve month high of $25.63. The company has a market cap of $7.96 billion, a price-to-earnings ratio of -0.92, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64. The company has a quick ratio of 0.37, a current ratio of 0.68 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date was Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 10.85%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analyst Upgrades and Downgrades

WBA has been the subject of several research analyst reports. UBS Group lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Evercore ISI increased their price target on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 16th. Barclays lifted their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Finally, Royal Bank of Canada dropped their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a report on Wednesday, December 4th. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.